4 completed. 4 Phase 2, 1 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 4 | Completed 4 |
| Phase 1 | 1 | Completed 1 |
Follow Bowel Dysfunction: new trials by email Literature Review of Bowel Dysfunction trials Research Report on Bowel Dysfunction
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Fiber and Water Improve Bowel Habit in Humans Fiber, Fiber and Water - Dietary Habits, Bowel Dysfunction | Phase 1 / Phase 2 | Completed | Universidade de Passo Fundo | 20 | 2015-08-01 | 2016-07-20 |
| Study 767905/008 Extension Study: Alvimopan for Treatment of Opioid-Induced Bowel Dysfunction in Cancer Pain Subjects alvimopan, placebo - Cancer, Bowel Dysfunction | Phase 2 | Completed | Cubist Pharmaceuticals LLC, a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA) | 67 | 2004-09-01 | 2015-09-02 |
| Study Of Alvimopan Drug For Treatment Of Constipation Due To Prescription Pain Medication alvimopan, placebo - Constipation, Bowel Dysfunction | Phase 2 | Completed | Cubist Pharmaceuticals LLC, a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA) | 233 | 2003-10-01 | 2017-08-30 |
| Methylnaltrexone in Patients With Opioid-Induced Bowel Dysfunction SC MNTX - Bowel Dysfunction | Phase 2 | Completed | Bausch Health Americas, Inc. | 39 | 2002-04-01 | 2019-11-27 |
Intestinal Diseases (4) · Constipation (2) · Opioid-Induced Constipation (2) · Cancer Pain (1) · Feeding Behavior (1) · Neoplasms (1)
Digestive System Diseases (4) · Gastrointestinal Diseases (4) · Pathological Conditions, Signs and Symptoms (3) · Signs and Symptoms (3) · Signs and Symptoms, Digestive (3) · Chemically-Induced Disorders (2) · Mental Disorders (2) · Narcotic-Related Disorders (2) · Substance-Related Disorders (2) · Behavior (1) · Behavior, Animal (1) · Constipation (1) · Neurologic Manifestations (1) · Pain (1)
alvimopan (2) · Dietary Fiber (1) · Water (1)
Cubist Pharmaceuticals LLC, a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA) (2) · Bausch Health Americas, Inc. (1) · Universidade de Passo Fundo (1)
United States (3) · Canada (2) · Finland (2) · France (2) · Hong Kong (2) · New Zealand (2) · Pakistan (2) · Peru (2) · Poland (2) · Portugal (2) · Russia (2) · Spain (2) · United Kingdom (2) · Argentina (1) · Australia (1)
Fernando Fornari, Professor (1) · Tage Ramakrishna, MD (1)